IDO1 and allergic disease: Evidence of gut microbial influence on TRP concentrations and IDO activity raises the question: could targeting the gut microbiome to modulate TRP metabolism and the KYN pathway treat or prevent diseases—specifically allergy? Studies of Bifidobacterium infantis have reported increases of TRP concentrations and KYN metabolites after colonization (92, 116).